KYMERA THERAPEUTICS, INC. (KYMR) Free cash flow 2019–2025
KYMERA THERAPEUTICS, INC. (KYMR) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$234.3MFY2025 · since FY2019: $17.4M → -$234.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$234.3M | -13.0% |
| FY2024 | -$207.3M | -51.0% |
| FY2023 | -$137.3M | +11.9% |
| FY2022 | -$155.9M | -19.4% |
| FY2021 | -$130.5M | -265.2% |
| FY2020 | $79.0M | +354.9% |
| FY2019 | $17.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice